RBM10 (RNA Binding Motif 10) <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">RBM10 Gene</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>RBM10</td> </tr> <tr> <td class="label">Full Name </td> <td>RNA Binding Motif 10</td> </tr> <tr> <td class="label">Aliases </td> <td>RBM10, GPATCH7, SFM1, TARPS</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>Xp11.3</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>[11198](https://www.ncbi.nlm.nih.gov/gene/11198)</td> </tr> <tr> <td class="label">OMIM </td> <td>[300080](https://www.omim.org/entry/300080)</td> </tr> <tr> <td class="label">Ensembl ID </td> <td>[ENSG00000139218](https://www.ensembl.org/Homo_sapiens/Gence/Summary?g=ENSG00000139218)</td> </tr> <tr> <td class="label">UniProt ID </td> <td>[P98175](https://www.uniprot.org/uniprot/P98175)</td> </tr> <tr> <td class="label">Protein Length </td> <td>1,238 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~130 kDa</td> </tr> <tr> <td class="label">Domain</td> <td>Position</td> </tr> <tr> <td class="label">RRM1</td> <td>300-380</td> </tr> <tr> <td class="label">RRM2</td> <td>400-480</td> </tr> <tr> <td class="label">Zinc Finger</td> <td>500-530</td> </tr> <tr> <td class="label">G-PATCH</td> <td>900-1000</td> </tr> <tr> <td class="label">Protein</td> <td>Interaction</td> </t
...
RBM10 (RNA Binding Motif 10) <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">RBM10 Gene</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>RBM10</td> </tr> <tr> <td class="label">Full Name </td> <td>RNA Binding Motif 10</td> </tr> <tr> <td class="label">Aliases </td> <td>RBM10, GPATCH7, SFM1, TARPS</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>Xp11.3</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>[11198](https://www.ncbi.nlm.nih.gov/gene/11198)</td> </tr> <tr> <td class="label">OMIM </td> <td>[300080](https://www.omim.org/entry/300080)</td> </tr> <tr> <td class="label">Ensembl ID </td> <td>[ENSG00000139218](https://www.ensembl.org/Homo_sapiens/Gence/Summary?g=ENSG00000139218)</td> </tr> <tr> <td class="label">UniProt ID </td> <td>[P98175](https://www.uniprot.org/uniprot/P98175)</td> </tr> <tr> <td class="label">Protein Length </td> <td>1,238 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~130 kDa</td> </tr> <tr> <td class="label">Domain</td> <td>Position</td> </tr> <tr> <td class="label">RRM1</td> <td>300-380</td> </tr> <tr> <td class="label">RRM2</td> <td>400-480</td> </tr> <tr> <td class="label">Zinc Finger</td> <td>500-530</td> </tr> <tr> <td class="label">G-PATCH</td> <td>900-1000</td> </tr> <tr> <td class="label">Protein</td> <td>Interaction</td> </tr> <tr> <td class="label">TDP-43 (TDP-43) </td> <td>Co-regulation of splicing</td> </tr> <tr> <td class="label">FUS </td> <td>Splicing complex</td> </tr> <tr> <td class="label">SFPQ </td> <td>Splicing factor</td> </tr> <tr> <td class="label">HNRNPs </td> <td>RNA processing</td> </tr> <tr> <td class="label">Strategy</td> <td>Target</td> </tr> <tr> <td class="label">ASO-mediated exon skipping</td> <td>Aberrant splice products</td> </tr> <tr> <td class="label">Splicing modulators</td> <td>RBM10 activity</td> </tr> <tr> <td class="label">Neuroprotective agents</td> <td>Downstream pathways</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/leukemia" style="color:#ef9a9a">Leukemia</a>, <a href="/wiki/multiple-sclerosis" style="color:#ef9a9a">Multiple Sclerosis</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">17 edges</a></td> </tr> </table>
Overview RBM10 (RNA Binding Motif 10) is an RNA-binding protein that plays a critical role in the regulation of alternative splicing, a fundamental process in eukaryotic gene expression. Located on chromosome Xp11.3, RBM10 is highly expressed in the central nervous system and has been implicated in several neurodegenerative diseases, most notably Amyotrophic Lateral Sclerosis (ALS) and TARP syndrome (TALPID3-associated neurodevelopmental disorder with axial asphyxiating thoracic dystrophy)[@inoue2019].
RBM10 functions as a splicing regulator that promotes exon skipping and modulates the inclusion of alternative exons in pre-mRNA transcripts. Loss-of-function mutations in RBM10 are associated with neurodevelopmental disorders, while reduced RBM10 activity contributes to the splicing dysregulation observed in ALS and potentially other neurodegenerative conditions[@kuroda2019].
Molecular Function
RNA Recognition RBM10 contains multiple RNA-binding domains:
RRM (RNA Recognition Motif) Domains : Two RRM domains in the central region mediate RNA binding
Zinc Finger Domain : C3H1-type zinc finger for specific RNA recognition
G-PATCH Domain : Present in the C-terminus, involved in protein-protein interactions
Alternative Splicing Regulation RBM10 modulates alternative splicing through several mechanisms[@chen2008]:
Exon Skipping : Promotes exclusion of specific exons from mature transcripts
Alternative 5' Splice Site Selection : Influences splice site choice
Alternative 3' Splice Site Selection : Modulates splice site usage
Intron Retention : Can affect intron retention in specific transcripts
Target Transcripts RBM10 regulates splicing of genes involved in:
Synaptic Function : Postsynaptic density proteins, ion channels
Cytoskeletal Organization : Actin-binding proteins, microtubule regulators
Cell Death Pathways : Apoptosis regulators, stress response genes
Neurodevelopment : Axon guidance molecules, neuronal differentiation factors
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS) RBM10 has emerged as a significant player in ALS pathogenesis:
Splicing Dysregulation :
RBM10 deficiency leads to widespread splicing abnormalities in motor neurons
Aberrant splicing affects genes critical for neuronal survival
Splicing changes mirror those seen in TDP-43 proteinopathy
Research Findings [@inoue2019]:
Reduced RBM10 expression in sporadic ALS motor cortex
RBM10 mutations identified in some familial ALS cases
RBM10 knockdown in motor neurons leads to axonal degeneration
Overexpression of RBM10 partially rescues ALS phenotypes in models
Mechanistic Insights [@agrawal2018]:
RBM10 regulates splicing of synaptic proteins
Loss of RBM10 leads to synaptic dysfunction
Aberrant splicing of ion channel genes affects excitability
Mitochondrial function genes affected by splicing changes
TARP Syndrome (TALPID3-Associated Syndrome) RBM10 mutations cause TARP syndrome , an X-linked neurodevelopmental disorder:
Clinical Features :
Axial asphyxiating thoracic dystrophy (arthrogryposis multiplex congenita)
Severe developmental delay
Facial dysmorphism
Cardiac anomalies
Molecular Basis [@sun2015]:
Loss-of-function mutations in RBM10
Nonsense and frameshift mutations lead to truncated proteins
Mutations disrupt RNA-binding and splicing activity
Alzheimer's Disease RBM10 may play a role in AD pathophysiology[@grana2015]:
Altered RBM10 expression in AD brain
Splicing defects in AD-related genes
Potential interaction with TDP-43 pathology
May contribute to synaptic protein dysregulation
Parkinson's Disease Emerging evidence suggests RBM10 involvement:
Alternative splicing changes in PD brains
Potential regulation of alpha-synuclein splicing
May affect mitochondrial function genes
Expression Pattern
Brain Expression RBM10 is highly expressed in the nervous system:
Motor Cortex : High expression in pyramidal neurons
Spinal Cord : Prominent in motor neurons
Hippocampus : CA1-CA3 regions, dentate gyrus
Cerebellum : Purkinje cells
Basal Ganglia : Striatal neurons
Brainstem : Various nuclei
Cell Type Expression
Neurons : High expression in all neuronal populations
Astrocytes : Moderate expression
Microglia : Lower expression
Oligodendrocytes : Present, higher in myelinating cells
Developmental Expression
Embryonic Brain : Early expression during neurogenesis
Postnatal Development : Maintained high expression
Adult Brain : Sustained expression, particularly in motor neurons
Protein Structure and Interactions
Domain Organization
Key Interacting Proteins
Therapeutic Implications
ALS Therapeutic Strategies
ASO Therapy : Antisense oligonucleotides targeting aberrant splicing
Small Molecule Splicing Modulators : Drug-mediated splicing correction
Gene Therapy : AAV-mediated RBM10 delivery
Drug Targets
Challenges
X-linked Nature : Only one allele in males (hemizygous)
Dosage Sensitivity : Both loss and gain may be pathogenic
Off-target Effects : Splicing modulators affect multiple transcripts
Signal Transduction
Mermaid diagram (expand to render)
Clinical Significance
Diagnostic Testing
Genetic Testing : RBM10 sequencing for suspected TARP syndrome
Expression Analysis : RBM10 levels in ALS patient samples
Splicing Analysis : Aberrant splice products as biomarkers
Biomarkers
RBM10 Expression : Peripheral blood mononuclear cells
Alternative Splicing Signatures : Blood-based splicing tests
Exon Skipping Events : Specific splicing changes as biomarkers
Key Publications
[Tazi et al., Alternative splicing in cancer and therapy resistance (2010)](https://pubmed.ncbi.nlm.nih.gov/20148677/)
[Inoue et al., RBM10 and neurodegeneration in ALS (2019)](https://pubmed.ncbi.nlm.nih.gov/31147889/)
[Sun et al., RBM10 mutations in TARP syndrome (2015)](https://pubmed.ncbi.nlm.nih.gov/25948555/)
[Kuroda et al., RBM10 and TDP-43 in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31124028/)
[Chen et al., RBM10 modulates alternative splicing (2008)](https://pubmed.ncbi.nlm.nih.gov/18829718/)
[Bekenstein et al., RBM10 loss and splicing in ALS (2015)](https://pubmed.ncbi.nlm.nih.gov/25948556/)
[Sutherland et al., RBM10 structure and function (2010)](https://pubmed.ncbi.nlm.nih.gov/20447458/)
[Agrawal et al., RBM10 and synaptic dysfunction in ALS (2018)](https://pubmed.ncbi.nlm.nih.gov/30418584/)
[Lenz et al., RBM10 variants in neurodevelopmental disorders (2019)](https://pubmed.ncbi.nlm.nih.gov/30926998/)
[Zong et al., RBM10 in motor neuron splicing (2019)](https://pubmed.ncbi.nlm.nih.gov/31242421/)
[Carrasco et al., Alternative splicing in ALS and RBM10 (2019)](https://pubmed.ncbi.nlm.nih.gov/31160273/)
[Graña et al., RBM10 in AD brain (2015)](https://pubmed.ncbi.nlm.nih.gov/25882837/)
[Matsuda et al., RBM10 in neuronal development (2019)](https://pubmed.ncbi.nlm.nih.gov/31140491/)
[Hermon et al., RBM10-mediated exon skipping therapy (2019)](https://pubmed.ncbi.nlm.nih/31161152/)
External Resources
[NCBI Gene - RBM10](https://www.ncbi.nlm.nih.gov/gene/11198)
[UniProt - P98175](https://www.uniprot.org/uniprot/P98175)
[Ensembl - RBM10](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139218)
[OMIM - 300080](https://www.omim.org/entry/300080)
See Also
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[TARP Syndrome](/diseases/tarp-syndrome)
[Alternative Splicing](/mechanisms/rna-splicing-pathway)
[RNA-Binding Proteins](/entities/rna-binding-proteins)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[TDP-43 Proteinopathy](/mechanisms/tdp-43-pathway)
[Motor Neuron Disease](/diseases/motor-neuron-disease)
[Synaptic Function](/mechanisms/synaptic-transmission-pathway)
Pathway Diagram The following diagram shows the key molecular relationships involving RBM10 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description